Navigating Formulation Change in the EU
By Matthew Weinberg
April 15, 2026
How to turn regulatory complexity into strategic strength
7 min read
False
Advertisement
Small Molecules
Trends and Challenges in Nitrosamine Testing: Part One – Scoping the Problem
April 3, 2026
In the first part of a new analytical science-focused series about all things nitrosamines, five experts share their first experiences, understanding of the danger, and comparisons with other industries
Precision Therapies: The Last Mile
By Pete Harbin
March 12, 2026
Why therapies still take years to reach the patients who need them
4 min read
Study Explores Liver Outcomes After HIV Treatment Switch
March 5, 2026
PASO DOBLE sub-analysis reports steatosis differences at 96 weeks
1 min read
Oral GLP-1s Won’t Win on Convenience – They’ll Win on CMC
By Achim Link
January 28, 2026
GLP-1 peptides validated the science. CMC will validate the small molecule modality for GLP-1 efficacy, scalability, and access.
4 min read
The Truth About Softgels: Phthalate-Free, Powered by Glycerin and Sorbitol
By Stephen Tindal
January 9, 2026
Catalent offers clarification after recent discussions raised concerns around softgels, phthalates and potential health risks
3 min read
A Turning Point in MASH
By HH Kim
January 8, 2026
A billion-dollar acquisition, breakthrough clinical data, and a shifting scientific paradigm are pushing MASH out of the shadows and into a new era of metabolic medicine.
3 min read
Understanding the Benefits of Gelatin and Collagen
November 27, 2025
Check out our interview from CPHI Frankfurt featuring GELITA’s Samy Jandall
Securing Europe’s Antibiotic Supply: A More Functional Future
October 31, 2025
The latest New Angle report discusses the status of Europe’s antibiotics supply chain, and how structural reform at the policy level is required to rectify it.
3 min read
Texas Takes on Tylenol
October 31, 2025
Texas Attorney General is suing Tylenol manufacturers, alleging misleading safety concerns and links with autism.
2 min read
